• Wed, March 3, 2021

by: WOPRAI

Robert Dodd Maintained (WHF) at Buy with Increased Target to $16 on, Mar 3rd, 2021

by: WOPRAI

Andrew Wittmann Upgraded (WSC) to Buy and Increased Target to $33 on, Mar 3rd, 2021

by: WOPRAI

Emily Chieng Upgraded (AA) to Strong Buy and Increased Target to $32 on, Mar 3rd, 2021

by: WOPRAI

Tyler Radke Initiated (ADBE) at Hold and Held Target at $523 on, Mar 3rd, 2021

by: WOPRAI

Salveen Richter Downgraded (ADPT) to Hold and Decreased Target to $63 on, Mar 3rd, 2021

by: WOPRAI

Brent Bracelin Maintained (VEEV) at Buy with Increased Target to $350 on, Mar 3rd, 2021

by: WOPRAI

Ryan MacDonald Maintained (VEEV) at Strong Buy with Increased Target to $336 on, Mar 3rd, 2021

by: WOPRAI

Stephanie Davis Maintained (VEEV) at Hold with Increased Target to $294 on, Mar 3rd, 2021

by: WOPRAI

Stan Zlotsky Maintained (VEEV) at Buy with Increased Target to $340 on, Mar 3rd, 2021

by: WOPRAI

Jerry Revich Maintained (URI) at Strong Buy with Increased Target to $330 on, Mar 3rd, 2021

by: WOPRAI

Patrick Hummel Maintained (TSLA) at Hold with Increased Target to $730 on, Mar 3rd, 2021

by: WOPRAI

Zachary Fadem Maintained (TSCO) at Buy with Increased Target to $180 on, Mar 3rd, 2021

by: WOPRAI

Ronald Epstein Maintained (SPCE) at Strong Buy on, Mar 3rd, 2021

by: WOPRAI

Paul Fremont Downgraded (BKH) to Hold and Decreased Target to $60 on, Mar 3rd, 2021

by: WOPRAI

Billy Kovanis Maintained (CAR) at Buy with Increased Target to $61 on, Mar 3rd, 2021

by: WOPRAI

Jerry Revich Maintained (CAT) at Strong Buy with Increased Target to $240 on, Mar 3rd, 2021

by: WOPRAI

Ricky Goldwasser Maintained (CAH) at Hold with Decreased Target to $64 on, Mar 3rd, 2021

by: WOPRAI

George Tong Initiated (BCO) at Strong Buy and Held Target at $92 on, Mar 3rd, 2021

by: WOPRAI

Umer Raffat Initiated (VOR) at Buy and Held Target at $48 on, Mar 3rd, 2021

by: WOPRAI

Carter Gould Initiated (VOR) at Buy and Held Target at $56 on, Mar 3rd, 2021

by: WOPRAI

Naved Khan Maintained (ABNB) at Hold with Increased Target to $180 on, Mar 3rd, 2021

by: WOPRAI

Richard Hill Maintained (AMH) at Hold with Increased Target to $33 on, Mar 3rd, 2021

by: WOPRAI

Quinn Bolton Maintained (AMBA) at Strong Buy with Increased Target to $140 on, Mar 3rd, 2021

by: WOPRAI

Joseph Moore Maintained (AMBA) at Buy with Increased Target to $137 on, Mar 3rd, 2021

by: WOPRAI

Tore Svanberg Maintained (AMBA) at Strong Buy with Increased Target to $135 on, Mar 3rd, 2021

by: WOPRAI

Suji Desilva Maintained (AMBA) at Strong Buy with Increased Target to $150 on, Mar 3rd, 2021

by: WOPRAI

Richard Shannon Maintained (AMBA) at Strong Buy with Increased Target to $150 on, Mar 3rd, 2021

by: WOPRAI

Samik Chatterjee Upgraded (ST) to Buy and Increased Target to $72 on, Mar 3rd, 2021

by: WOPRAI

James Faucette Maintained (TTEC) at Hold with Increased Target to $87 on, Mar 3rd, 2021

by: WOPRAI

Jed Dorsheimer Maintained (AMRC) at Strong Buy with Increased Target to $82 on, Mar 3rd, 2021

by: WOPRAI

Damian Karas Maintained (AOS) at Hold with Increased Target to $62 on, Mar 3rd, 2021

by: WOPRAI

Luke Sergott Initiated (TMO) at Buy and Held Target at $525 on, Mar 3rd, 2021

by: WOPRAI

Peter Benedict Maintained (TGT) at Buy with Decreased Target to $200 on, Mar 3rd, 2021

by: WOPRAI

Mark Astrachan Maintained (TGT) at Strong Buy with Decreased Target to $220 on, Mar 3rd, 2021

by: WOPRAI

Michael Baker Maintained (TGT) at Strong Buy with Decreased Target to $210 on, Mar 3rd, 2021

by: WOPRAI

Stephanie Wissink Maintained (TGT) at Hold with Decreased Target to $188 on, Mar 3rd, 2021

by: WOPRAI

Kelly Bania Maintained (TGT) at Buy with Increased Target to $205 on, Mar 3rd, 2021

by: WOPRAI

Michael Lasser Maintained (TGT) at Hold with Decreased Target to $185 on, Mar 3rd, 2021

by: WOPRAI

Kate McShane Maintained (TGT) at Strong Buy with Decreased Target to $212 on, Mar 3rd, 2021

by: WOPRAI

Joshua Wilson Maintained (TGLS) at Buy with Increased Target to $10 on, Mar 3rd, 2021

by: WOPRAI

Devin Ryan Initiated (TCPC) at Buy and Held Target at $15 on, Mar 3rd, 2021

by: WOPRAI

Jack Meehan Initiated (AVTR) at Buy and Held Target at $33 on, Mar 3rd, 2021

  • Thu, March 4, 2021

by: WOPRAI

Jonathan Reeder Upgraded (BEP) to Hold and Decreased Target to $42 on, Mar 4th, 2021

by: WOPRAI

Pavel Molchanov Upgraded (BE) to Buy and Held Target at $33 on, Mar 4th, 2021

by: WOPRAI

Richard Repetto Upgraded (CBOE) to Buy and Increased Target to $108 on, Mar 4th, 2021

by: WOPRAI

Shyam Patil Initiated (BMBL) at Buy and Held Target at $78 on, Mar 4th, 2021

by: WOPRAI

Andrew DeGasperi Initiated (BL) at Strong Buy and Held Target at $150 on, Mar 4th, 2021

by: WOPRAI

Ken Hoexter Upgraded (SNDR) to Strong Buy and Increased Target to $28 on, Mar 4th, 2021

Carter Gould Initiated (VOR) at Buy and Held Target at $56 on, Mar 3rd, 2021

Carter Gould of Barclays, Initiated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $56 on, Mar 3rd, 2021.

Carter has made no other calls on VOR in the last 4 months.



There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with Carter's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Carter

  • Graig Suvannavejh of "Goldman Sachs" Initiated at Strong Sell and Held Target at $19 on, Tuesday, March 2nd, 2021
  • Stephen Willey of "Stifel" Initiated at Strong Buy and Held Target at $58 on, Tuesday, March 2nd, 2021

Like: 👍